EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Preventing severe hypoglycemia in adults with type 2 diabetes (PHT2): Design, delivery and evaluation framework for a randomized controlled trial

James D Ralston, Melissa Anderson, Janet Ng, Ayat Bashir, Kelly Ehrlich, Dena Burns-Hunt, Meredith Cotton, Laurel Hansell, Clarissa Hsu, Helen Hunt, Andrew J Karter, Shaula M Levy und 13 weitere

Contemporary Clinical Trials · 2024

DOI: 10.1016/j.cct.2024.107456 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von James D Ralston und 24 weiteren Autor:innen. Beteiligte Einrichtung: Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave, Seattle, WA 98101, USA; Washington Permanente Medical Group, 125 16th Ave E, …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Patient-Centered Outcomes Research Institute, NIDDK NIH HHS, Diabetes UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Severe hypoglycemia is a common and feared complication of medications used to lower blood glucose levels in individuals with diabetes. Psychoeducational interventions can prevent severe hypoglycemia in individuals with type 1 diabetes (T1D). We aim to determine the effectiveness of this approach among adults with type 2 diabetes (T2D) at elevated risk for severe hypoglycemia. METHODS: Preventing Hypoglycemia in Type 2 diabetes (PHT2) is a two-arm, parallel, randomized controlled trial. Participants are eligible if they are adults with T2D receiving care at an integrated group practice in Washington state and have experienced one or more episodes of severe hypoglycemia in the prior 12 months or have impaired awareness of hypoglycemia (Gold score ≥ 4). Participants are randomized to proactive nurse care management with or without my hypo compass, an evidence-based, psychoeducational intervention combining group and individual self-management training. For this study, my hypo compass was adapted to be suitable for adults with T2D and from an in-person to a virtual intervention over videoconference and telephone. The primary outcome is any self-reported severe hypoglycemia in the 12 months following the start of the intervention. Secondary outcomes include biochemical measures of hypoglycemia, self-reported hypoglycemia awareness, fear of hypoglycemia, and emergency department visits and hospitalizations for severe hypoglycemia. The study includes a process evaluation to assess implementation fidelity and clarify the causal pathway. CONCLUSION: The PHT2 trial will compare the effectiveness of two approaches for reducing severe hypoglycemia in adults with T2D. TRIAL REGISTRATION: clinicaltrials.gov, # NCT04863872.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2HypoglycemiaAdultHumansBlood GlucoseBlood Glucose Self-MonitoringHypoglycemic AgentsInsulinRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

HypoglycemiaImpaired awareness of hypoglycemiaType 2 diabetes

Substanzen

Blood GlucoseHypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave, Seattle, WA 98101, USA; Washington Permanente Medical Group, 125 16th Ave E, Seattle, WA, USA. Electronic address: james.d.ralston@kp.org.
  • Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave, Seattle, WA 98101, USA.
  • Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
  • Kaiser Permanente Washington, 2715 Naches Ave SW, Renton, WA 98057, USA.
  • Department of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, USA.
  • Washington Permanente Medical Group, 125 16th Ave E, Seattle, WA, USA.

Förderung

  • Patient-Centered Outcomes Research Institute
  • NIDDK NIH HHS
  • Diabetes UK
  • Newcastle University

Zitieren

APA

Ralston, J. D., Anderson, M., Ng, J., Bashir, A., Ehrlich, K., Burns-Hunt, D., Cotton, M., Hansell, L., Hsu, C., Hunt, H., Karter, A. J., Levy, S. M., Ludman, E., Madziwa, L., Omura, E. M., Rogers, K., Sevey, B., Shaw, J. A. M., Shortreed, S. M., …, & Yarborough, L. (2024). Preventing severe hypoglycemia in adults with type 2 diabetes (PHT2): Design, delivery and evaluation framework for a randomized controlled trial. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107456

Vancouver

Ralston JD, Anderson M, Ng J, Bashir A, Ehrlich K, Burns-Hunt D, et al. Preventing severe hypoglycemia in adults with type 2 diabetes (PHT2): Design, delivery and evaluation framework for a randomized controlled trial. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2024.107456

BibTeX
@article{Ralston2024,
  author = {Ralston, James D and Anderson, Melissa and Ng, Janet and Bashir, Ayat and Ehrlich, Kelly and Burns-Hunt, Dena and Cotton, Meredith and Hansell, Laurel and Hsu, Clarissa and Hunt, Helen and Karter, Andrew J and Levy, Shaula M and Ludman, Evette and Madziwa, Lawrence and Omura, Emily M and Rogers, Kristine and Sevey, Brandie and Shaw, James A M and Shortreed, Susan M and Singh, Umesh and Speight, Jane and Sweeny, Amber and Tschernisch, Katherine and Sergei Tschernisch, S and Yarborough, Laura},
  title = {Preventing severe hypoglycemia in adults with type 2 diabetes (PHT2): Design, delivery and evaluation framework for a randomized controlled trial},
  journal = {Contemporary Clinical Trials},
  year = {2024},
  doi = {10.1016/j.cct.2024.107456}
}
Kostenlos starten →